Oral erythromycin for treatment of gastrointestinal dysmotility in premature infants
Background Functional immaturity of gastrointestinal (GI) motility predisposes preterm infants to feeding intolerance. Erythromycin as a prokinetic agent has been given to preterm infants for the management of non-obstructive GI dysmotility. Objective To evaluate the efficacy of oral erythromycin fo...
Main Authors: | Armelia Moesri, Bugis Mardina Lubis, Asrul Asrul, Atan Baas Sinuhaji, Guslihan Dasa Tjipta |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Pediatric Society Publishing House
2007-10-01
|
Series: | Paediatrica Indonesiana |
Subjects: | |
Online Access: | https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/421 |
Similar Items
-
Recent Advances in the Management of Severe Gastrointestinal Dysmotility
by: Vasant DH, et al.
Published: (2021-05-01) -
Factors associated with gastrointestinal dysmotility in critically ill patients
by: Petrović Nemanja, et al.
Published: (2023-10-01) -
Early presenting hypertrophic pyloric stenosis with transient antroduodenal dysmotility in a preterm neonate: A case report
by: Sang-won Cho, et al.
Published: (2015-09-01) -
Effect of oral erythromycin in the treatment of preterm infants with feeding intolerance
by: Yasser Abdel Rahman Ahmed, et al.
Published: (2020-01-01) -
Autoimmune gastrointestinal dysmotility: the interface between clinical immunology and neurogastroenterology
by: Shunya Nakane, et al.
Published: (2021-04-01)